Cargando…
Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
Antiplatelet agents offer a desirable approach to thrombosis prevention through the reduction of platelet reactivity. However, major bleeding events greatly attenuate the clinical outcomes of most antithrombotic agents. Therefore, the development of safer and more effective strategies to prevent vas...
Autores principales: | He, Hongliang, Adili, Reheman, Liu, Lisha, Hong, Kristen, Holinstat, Michael, Schwendeman, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821904/ https://www.ncbi.nlm.nih.gov/pubmed/33277254 http://dx.doi.org/10.1126/sciadv.abd0130 |
Ejemplares similares
-
Development of activated endothelial targeted high-density lipoprotein nanoparticles
por: Yu, Minzhi, et al.
Publicado: (2022) -
Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
por: Yuan, Yue, et al.
Publicado: (2016) -
Slounase, a Batroxobin Containing Activated Factor X
Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding
in Hypocoagulant Conditions in Mice
por: Adili, Reheman, et al.
Publicado: (2021) -
Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
por: Kuai, Rui, et al.
Publicado: (2017) -
Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
por: Duan, Xin, et al.
Publicado: (2021)